Recall of Teva's Propofol Injectable Emulsion, 10 mg/mL 100 mL vials

Recall of Teva's Propofol Injectable Emulsion, 10 mg/mL 100 mL vials
July 17, 2009
Audience: Anesthesia healthcare professionals, hospital risk managers.

Teva Pharmaceuticals and FDA notified healthcare professionals of a
recall of Propofol Injectable Emulsion 10 mg/mL 100 mL vials, lot
numbers 31305429B and 31305430B. The product lots identified are being
recalled due to the presence of elevated endotoxin levels in some
vials within these lot numbers. Teva has been notified of 41
propofol-treated patients who experienced post-operative fever, chills
and other flu-like symptoms.